Consultant
CurrentI am a provider of contract/consulting services to the pharmaceutical research industry. My focus is primarily in bioanalytical, information technology, and quality systems regulated under the FDA's Good Laboratory Practices (21 CFR Part 58). With a strong background in both large and small molecule analysis for pharmacokinetics, ADA, and NAb, data and.